Waner J L, Biano S A
J Clin Microbiol. 1979 Jan;9(1):134-40. doi: 10.1128/jcm.9.1.134-140.1979.
Human fibroblasts were infected with vervet cytomegalovirus (VCMV) and cultured in medium containing 50 micrograms of cytosine arabinoside per ml for 72 h. Early antigens (EAg) were detected in the nuclei of infected cells by an indirect fluorescent antibody test with human sera having antibody to EAg of human cytomegalovirus (HCMV). Sera from patients with serological and/or virological evidence of active HCMV infection and from asymptomatic blood donors were examined for antibody activity with the HCMV and VCMV EAg's. The HCMV and VCMV EAg's were comparable in detecting levels of antibody activity and fluctuations in antibody titer of paired sera from patients. A total of 81% of patient sera reactive with HCMV EAg were also reactive with VCMV EAg. In contrast, only 14% of the asymptomatic donor sera reactive with HCMV EAg were also reactive with VCMV EAg. The VCMV EAg, therefore, appeared to differentiate latent from active infections in humans more effectively than did HCMV EAg.
用人巨细胞病毒(VCMV)感染人成纤维细胞,并在每毫升含50微克阿糖胞苷的培养基中培养72小时。通过间接荧光抗体试验,用具有抗人巨细胞病毒(HCMV)早期抗原(EAg)抗体的人血清在感染细胞的细胞核中检测早期抗原(EAg)。检测有血清学和/或病毒学证据的活动性HCMV感染患者以及无症状献血者的血清中针对HCMV和VCMV EAg的抗体活性。HCMV和VCMV EAg在检测患者配对血清的抗体活性水平和抗体滴度波动方面具有可比性。与HCMV EAg反应的患者血清中,共有81%也与VCMV EAg反应。相比之下,与HCMV EAg反应的无症状献血者血清中,只有14%也与VCMV EAg反应。因此,VCMV EAg似乎比HCMV EAg更有效地区分人类的潜伏感染和活动性感染。